Skip to main content

Assenagon Asset Management S.A.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1546007 SENNINGERBERG, N4

Position in NBIX

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$12,051,311
+$703,210 QoQ
Shares Held
91,478
+14.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Assenagon Asset Management S.A. holds $291,766,020 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
91,478 $12,051,311

All Filings in NBIX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,051,311 91,478
2025-12-31 $11,348,101 80,012
2025-09-30 $6,590,419 46,947
2025-06-30 $7,569,931 60,227
2025-03-31 $43,516,123 393,455
2024-12-31 $3,568,110 26,140
2024-09-30 $3,433,901 29,803
2024-06-30 $34,338,202 249,424
2024-03-31 $46,580,687 337,737
2023-12-31 $41,578,185 315,560
2023-09-30 $65,760,637 584,539
2023-06-30 $24,987,142 264,975
2023-03-31 $9,161,219 90,508
2022-12-31 $24,894,998 208,431
2022-09-30 $9,008,519 84,818
2022-06-30 $13,595,633 139,471
2022-03-31 $1,299,375 13,860
2021-12-31 $7,309,715 85,825
2021-09-30 $1,073,328 11,191
2021-06-30 $4,775,395 49,069
2021-03-31 $314,409 3,233
2020-06-30 $2,796,972 22,926